Qing-Bin Lu

Dr. Qing-Bin Lu

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZLZhong-Jie Li
Zhong-Jie Li
HZHai-Yang Zhang
Hai-Yang Zhang
LRLi-Li Ren
Li-Li Ren
QLQing-Bin Lu
Qing-Bin Lu
XRXiang Ren
Xiang Ren
WYWei-Zhong Yang
Wei-Zhong Yang
Nationwide prospective surveillance of all-age patients with acute respiratory infections was conducted in China between 2009‒2019. Here we report the etiological and epidemiological features of the 231,107 eligible patients enrolled in this analysis. Children <5 years old and school-age children have the highest viral positivity rate (46.9%) and bacterial positivity rate (30.9%). Influenza virus, respiratory syncytial virus and human rhinovirus are the three leading viral pathogens with proportions of 28.5%, 16.8% and 16.7%, and Streptococcus pneumoniae, Mycoplasma pneumoniae and Klebsiella pneumoniae are the three leading bacterial pathogens (29.9%, 18.6% and 15.8%). Negative interactions between viruses and positive interactions between viral and bacterial pathogens are common. A Join-Point analysis reveals the age-specific positivity rate and how this varied for individual pathogens. These data indicate that differential priorities for diagnosis, prevention and control should be highlighted in terms of acute respiratory tract infection patients’ demography, geographic locations and season of illness in China.

20 August 2013 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
WLWei Liu
Wei Liu
QLQing-Bin Lu
Qing-Bin Lu
NCNing Cui
Ning Cui
HLHao Li
Hao Li
LWLi-Yuan Wang
Li-Yuan Wang
WCWu-Chun Cao
Wu-Chun Cao
Background. The wide distribution and high case-fatality ratio of severe fever with thrombocytopenia syndrome (SFTS) have made it a significant public health problem. This study was designed to identify the predictors of fatal outcomes and to evaluate the effectiveness of antiviral therapy in treating SFTS virus (SFTSV)–infected patients. Methods. A cross-sectional study was performed in a general hospital located in Xinyang city, whereas the largest number of patients with SFTS in China were treated during 2011–2012. The primary outcome for the treatment effect analysis was death. Other outcomes included sequential platelet levels and viral loads observed throughout the hospitalization and the interval between the initiation of ribavirin therapy and the return of the platelet count to a normal level. Results. A total of 311 SFTSV-infected patients were included in the study. The most frequent clinical presentations were fever, weakness, myalgia, and gastrointestinal symptoms. Each patient had thrombocytopenia, leukopenia, or both. The case-fatality ratio (CFR) was 17.4% (95% confidence interval [CI], 13.1%–21.6%). Older age (odds ratio [OR], 1.061; 95% CI, 1.023–1.099; P = .001), decreased level of consciousness (OR, 5.397; 95% CI, 2.660–10.948; P < .001), and elevated levels of lactate dehydrogenase (>1200 U/L; OR, 2.620; 95% CI, 1.073–6.399; P = .035) and creatine kinase (>800 U/L; OR, 2.328; 95% CI, 1.129–4.800; P = .022) were significantly associated with fatal outcome. The CFRs were similar between patients who received ribavirin and those who did not. Ribavirin treatment showed no significant effect on either platelet counts or viral loads during hospitalization of patients with fatal or nonfatal cases. Conclusions. These findings can improve knowledge about the characteristics of patients with fatal outcomes and the use of antiviral drug for SFTS.

11 February 2020 in medRxiv
Verified
Preprint
Open access
PDF file
YYYang Yang
Yang Yang
QLQing-Bin Lu
Qing-Bin Lu
MLMing-Jin Liu
Ming-Jin Liu
YWYi-Xing Wang
Yi-Xing Wang
AZAn-Ran Zhang
An-Ran Zhang
LFLi-Qun Fang
Li-Qun Fang
Our manuscript was based on surveillance cases of COVID-19 identified before January 26, 2020. As of February 20, 2020, the total number of confirmed cases in mainland China has reached 18 times of the number in our manuscript. While the methods and the main conclusions in our original analyses remain solid, we decided to withdraw this preprint for the time being, and will replace it with a more up-to-date version shortly. Should you have any comments or suggestions, please feel free to contact the corresponding author.

29 April 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
LWLi-Ping Wang
Li-Ping Wang
SZShi-Xia Zhou
Shi-Xia Zhou
XWXin Wang
Xin Wang
QLQing-Bin Lu
Qing-Bin Lu
LSLu-Sha Shi
Lu-Sha Shi
WYWei-Zhong Yang
Wei-Zhong Yang
National-based prospective surveillance of all-age patients with acute diarrhea was conducted in China between 2009‒2018. Here we report the etiological, epidemiological, and clinical features of the 152,792 eligible patients enrolled in this analysis. Rotavirus A and norovirus are the two leading viral pathogens detected in the patients, followed by adenovirus and astrovirus. Diarrheagenic Escherichia coli and nontyphoidal Salmonella are the two leading bacterial pathogens, followed by Shigella and Vibrio parahaemolyticus. Patients aged <5 years had higher overall positive rate of viral pathogens, while bacterial pathogens were more common in patients aged 18‒45 years. A joinpoint analysis revealed the age-specific positivity rate and how this varied for individual pathogens. Our findings fill crucial gaps of how the distributions of enteropathogens change across China in patients with diarrhea. This allows enhanced identification of the predominant diarrheal pathogen candidates for diagnosis in clinical practice and more targeted application of prevention and control measures.

1 May 2021 in Vaccine
Verified
Journal Article
Closed access
CWChao Wang
Chao Wang
BHBingfeng Han
Bingfeng Han
TZTianshuo Zhao
Tianshuo Zhao
HLHanyu Liu
Hanyu Liu
BLBei Liu
Bei Liu
FCFuqiang Cui
Fuqiang Cui

17 October 2020 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
DMDong Miao
Dong Miao
MLMing-Jin Liu
Ming-Jin Liu
YWYi-Xing Wang
Yi-Xing Wang
XRXiang Ren
Xiang Ren
QLQing-Bin Lu
Qing-Bin Lu
WLWei Liu
Wei Liu
Background: The growing epidemics of severe fever with thrombocytopenia syndrome (SFTS), an emerging tick-borne disease in East Asia, and its high case fatality rate have raised serious public health concerns. Methods: Surveillance data on laboratory-confirmed SFTS cases in China were collected. The spatiotemporal dynamics and epidemiological features were explored. The socioeconomic and environmental drivers were identified for SFTS diffusion using survival analysis and for SFTS persistence using a two-stage generalized boosted regression tree model. Results: During 2010‒2018, a total of 7721 laboratory-confirmed SFTS cases were reported in China, with an overall case fatality rate (CFR) of 10.5%. The average annual incidence increased >20 times and endemic areas expanded from 27 to 1574 townships, whereas the CFR declined from 19% to 10% during this period. Four geographical clusters—the Changbai Mountain area, the Jiaodong Peninsula, the Taishan Mountain area, and the Huaiyangshan Mountain area—were identified. Diffusion and persistence of the disease were both driven by elevation, high coverages of woods, crops, and shrubs, and the vicinity of habitats of migratory birds but had different meteorological drivers. Residents ≥60 years old in rural areas with crop fields and tea farms were at increased risk to SFTS. Conclusions: Surveillance of SFTS and intervention programs need to be targeted at areas ecologically suitability for vector ticks and in the vicinity of migratory birds to curb the growing epidemic.